Viewing Study NCT06069934


Ignite Creation Date: 2025-12-25 @ 2:33 AM
Ignite Modification Date: 2026-05-09 @ 2:20 PM
Study NCT ID: NCT06069934
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-05-18
First Post: 2023-09-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)
Sponsor: Prilenia
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PL101-ALS501
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None NIH View
None NIH View